Please login to the form below

Not currently logged in
Email:
Password:

Fresenius Kabi

This page shows the latest Fresenius Kabi news and features for those working in and with pharma, biotech and healthcare.

Data integrity scuppers Fresenius deal with Akorn

Data integrity scuppers Fresenius deal with Akorn

German healthcare group Fresenius Kabi has abandoned plans to acquire US generic and over-the-counter drugmaker Akorn in a $4.3bn deal, citing FDA compliance issues. ... Fresenius raised the data integrity question and said it was launching an

Latest news

More from news
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    following an announcement as seen with BD and Cardinal Health.  It is encouraging, therefore, to see Fresenius’s share price increase by 2% following the announcement that its subsidiary Fresenius Kabi ... 6, 100. Akorn (US). Fresenius (DE). Company

  • Pharma deals during March 2013 Pharma deals during March 2013

    39.5. Goa Formulations/ Fresenius Kabi India. Acquisition. Manufacturer of drugs including intravenous fluids.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Hikma appoints group scientific officer and global head of R&D Hikma appoints group scientific officer and global head of R&D

    Dr Surendera Tyagi joins the pharma group from Fresenius Kabi. Speciality pharmaceutical group Hikma has appointed a group scientific officer and gloval head of R&D in the form of Dr ... He joins the pharma group from Fresenius Kabi, where he most

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma.

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories.

  • Biotest makes two senior management appointments Biotest makes two senior management appointments

    Promotion for Jörg Schüttrumpf while Markus Rothenburger joins from Fresenius Kabi. ... Prof Rothenburger joins Biotest from his role as VP medical and clinical affairs at Fresenius Kabi.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics